Smartphone Magnetometer Uses Magnetized Hydrogel to Measure Biomarkers for Disease Diagnosis
|
By HospiMedica International staff writers Posted on 03 Apr 2024 |

Almost every modern smartphone incorporates a compass or magnetometer, which senses Earth's magnetic field, crucial for navigation purposes. Now, a newly developed technique uses an ordinary cellphone magnetometer to precisely measure glucose levels, an important diabetes indicator. This approach, combined with magnetic materials that change their shape in reaction to biological or environmental stimuli, can be employed to assess a wide array of biomedical properties crucial for human disease monitoring or diagnosis, as well as detecting environmental pollutants.
In their proof-of-concept study, a team of researchers at the National Institute of Standards and Technology (NIST, Gaithersburg, MD, USA) attached a tiny well filled with the test solution and a hydrogel strip, to a smartphone. This hydrogel, a porous material that swells when immersed in water, was embedded with tiny magnetic particles engineered to respond to glucose presence or pH changes by swelling or contracting. Changing pH levels is associated with various biological disorders. When the hydrogels enlarged or shrank, they forced the magnetic particles to come closer to or go farther from the cellphone’s magnetometer, which detected the corresponding changes in the strength of the magnetic field. Utilizing this innovative approach, the team succeeded in measuring glucose concentrations as small as a few millionths of a mole levels. Although such high sensitivity is not needed for home glucose monitoring using blood tests, it could pave the way for saliva-based glucose testing, where sugar concentration is notably lower.
The method's simplicity, without the need for any additional electronics or power sources except for the smartphone or requirement for sample processing, presents an economical solution for widespread testing, even in resource-limited areas. Future potential improvements in measuring accuracy through smartphone magnetometers could lead to detection of DNA, specific proteins, and histamines — key immune response elements — at extremely low concentrations. For example, accurately measuring histamines, typically found in urine at concentrations ranging from about 45 to 190 nanomoles, would usually require a 24-hour urine collection and complex lab analyses. Similarly, the team found that a cellphone magnetometer can measure pH levels with sensitivity equal to a thousand-dollar benchtop meter but at a substantially lower cost. To make smartphone-based measurements a market success, engineers will have to devise a mass-production strategy for the hydrogel test strips and ensure their long shelf life.
Related Links:
NIST
Latest Critical Care News
- Implantable Wireless Light Device Advance Bladder Cancer Treatment
- Smart Wristband Technology Detects Cardiac Arrest and Alerts Responders
- FDA-Cleared Home Sleep Test Enables Multi-Night Diagnosis of Sleep Apnea
- AI-Enabled Wearable Patches Reveal Undetected Hormone Disruption in Infertility
- AI Method Turns Toe Scan into Rapid PAD Screening Tool
- Integrated AI Pulmonary Workflow System Streamlines Detection and Follow-Up
- AI Model Predicts 10-Year Stroke Risk from Standard ECG
- Portable Ultrasound Tool Quantifies Liver Fat with MRI-Like Accuracy
- AI Tool Predicts Risk of Out-of-Hospital Cardiac Arrest
- Implantable Cytokine Device Enables Localized Immunotherapy for Ovarian Cancer
- Wearable Defibrillator Supports Quicker Beta-Blocker Optimization in Women
- High-Frequency Ultrasound Disables Viruses While Sparing Human Cells
- New Nasal Spray Enables Prehospital Neuroprotection in Ischemic Stroke
- AI-Enhanced ECG Screens for Heart Failure Risk in Resource-Limited Settings
- Single-Lead AI ECG Tool Detects Moderate-to-Severe Hyperkalemia Outside Clinic
- Reduced-Intensity Transplant Regimen Expands Donor Access in Sickle Cell Disease
Channels
Artificial Intelligence
view channel
Automated Phone Speech Test Identifies Alzheimer’s Pathology for Prescreening
Alzheimer’s disease assessment and trial recruitment often rely on costly, invasive biomarker testing and clinic-based cognitive evaluations, limiting scalability as populations age. Providers and trial... Read more
FDA-Cleared AI System Detects Sepsis Earlier and Reduces Mortality
Sepsis remains one of the deadliest complications for hospitalized patients, in part because its early signs overlap with other conditions. Each hour of delayed recognition measurably decreases survival,... Read moreSurgical Techniques
view channel
BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures
BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Stretchable Bioelectronic Implant Lowers Blood Pressure in Preclinical Study
Hypertension, or high blood pressure, drives major cardiovascular morbidity and affects nearly half of adults in the United States. About one in ten patients develop drug‑resistant hypertension that persists... Read more
FDA-Cleared Nerve Stimulator Advances Intraoperative Peripheral Nerve Assessment
The Evala Nerve Stimulator from Epineuron (Mississauga, ON, Canada) is a handheld, intraoperative electrical stimulation system designed to provide surgeons with a rapid and accurate method for nerve identification... Read morePatient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read moreHealth IT
view channel
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read more
AI System Detects and Quantifies Chronic Subdural Hematoma
Viz.ai (San Francisco, CA, USA) announced a strategic commercialization collaboration with Johnson & Johnson (New Brunswick, NJ, USA) to expand access in the United States to the Viz Subdural solution... Read more
Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more
Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings
Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read morePoint of Care
view channel
Point-of-Care Viscoelastic Testing System Supports Obstetric Bleeding Management
HemoSonics (Durham, NC, USA) announced on May 5, 2026 that the company's Quantra Hemostasis System for Obstetric Procedures won Silver in the 2026 Edison Awards in the Women’s Health and Reproductive Innovations... Read moreBusiness
view channel
Olympus Partnership Aims to Expand Access to Robot-Assisted Endoscopic Therapy
Olympus has signed an exclusive global distribution agreement with EndoRobotics Co., Ltd., under which robot-assisted technologies developed by EndoRobotics will be distributed worldwide as part of the... Read more







